GFM2 helps mitochondria, the parts of cells that make energy, finish making proteins needed for normal energy production. This gene plays an important role in keeping energy supply steady, especially in the brain, muscles, and other tissues that use a lot of energy. If the GFM2 gene does not work properly, cells may struggle to make enough energy, which can lead to a mitochondrial condition with developmental delay, low muscle tone, movement problems, seizures, or lactic acid buildup in the blood. GFM2 is known in medical genetics, not popular culture.
What is a gene?
A gene is a piece of DNA that carries instructions your cells use to make molecules or guide processes throughout the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others are mainly involved in controlling when certain processes happen, where they happen, and how active they are. As a group, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
GFM2Gene function
What if the gene works
The GFM2 gene helps mitochondria reset their protein building machinery after a protein is finished. This supports the steady production of proteins that help cells make energy.
Risk
What if the gene does not work
Variants in the GFM2 gene can reduce mitochondrial energy production and cause a mitochondrial condition with developmental delay, seizures, or movement problems. Effects can range from milder to more severe, influencing when symptoms begin and how prominent they are.
Treatment
What does that mean for your treatment
No GFM2-specific treatment or management approach is currently established, so care is not guided by a pathogenic variant in the GFM2 gene in the way it is for some other genes.
Conditions associated with GFM2
Gene function
What if the gene works
Your cells need GFM2 to keep their mitochondria, the parts that make most of the cell’s energy, working smoothly. Inside mitochondria, GFM2 helps reset the protein making machinery after each protein is finished. This supports a steady supply of the proteins mitochondria need for daily energy production.
GFM2 helps separate and clear mitochondrial ribosomes after a protein is finished. This reset step gets the machinery ready for the next round of protein making.
Mitochondria make a small set of proteins inside their own compartment. GFM2 supports this process by helping one protein making cycle end cleanly before the next one starts.
By helping mitochondrial protein production run smoothly, GFM2 supports the cell systems that release usable energy from food and oxygen. This is especially important in tissues with high energy needs, such as the brain, muscles, and heart.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help create normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GFM2 gene can change the shape, stability, or ribosome binding of this protein-making factor in mitochondria, which helps explain how GFM2 gene variants affect mitochondrial protein production. Some variants leave partial activity, while more disruptive variants can sharply reduce or abolish ribosome recycling, a key step that resets the cell's mitochondrial protein-making machinery. This can lower the supply of proteins made in mitochondria and weaken the energy-making complexes that depend on them.
How variants are linked to conditions
Pathogenic variants in the GFM2 gene cause a rare inherited mitochondrial condition within the combined oxidative phosphorylation deficiency group. People with a confirmed diagnosis may have developmental delay, low muscle tone, feeding problems, seizures, hearing loss, or trouble with movement and balance, often beginning in infancy or childhood. Symptoms and severity vary from person to person. This summary of GFM2 gene variants linked to mitochondrial disease reflects the main condition association reported in human genetics.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common throughout the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors play a role. In some cases, however, a single well-characterized variant in a particular gene can be enough to confirm the diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to GFM2. For many living with a change in this gene, risk is mainly shaped by the genetic change itself rather than well-established lifestyle or environmental factors, and a doctor or genetic counselor can help explain personal and family risk.
Inheritance of GFM2 variants
GFM2-related conditions are inherited in an autosomal recessive pattern. This means a child usually develops the condition only after inheriting one altered copy of the GFM2 gene from each parent. Parents who carry one variant are typically healthy carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child without the familial variant. This is the usual explanation of how GFM2 variants are inherited in families.
What does my GFM2 result mean for my family?
Changes in the GFM2 gene are linked to a condition that usually runs in families in a recessive way, so close relatives may also be carriers even if they are healthy. Brothers and sisters could be affected or could carry the same gene change, while parents are often carriers. For future children in the family, the chance depends on whether both parents carry a GFM2 change.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the GFM2 gene, a lab reads DNA from a blood, saliva, or cheek swab sample. Genetic testing for the GFM2 gene checks the gene’s code for variants and compares it with the usual sequence. Results may show a known disease-causing variant, no relevant variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the GFM2 gene may be considered when a child has signs of a rare condition that affects how the body’s cells make energy, such as early developmental delay, low muscle tone, seizures, or feeding problems. It can also help when there is a family history of a similar condition or an affected sibling.
A genetic result is only one part of your health story
A genetic result can provide valuable information, but how much it can explain varies by the condition and the type of variant involved. The way the body functions over time is also shaped by many other factors, including age, environment, lifestyle, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, it can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person but cause fewer benefits or more side effects in another. These differences are common and are one part of how clinicians understand medication response alongside age, kidney and liver function, and other health factors.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences can shape a person’s response to medications. It focuses on gene drug patterns to help explain why the same treatment may not work the same way for everyone. For many medicines, genes can influence how strong a drug’s effects are or how the body handles it. This information can support treatment choices that are better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the GFM2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting medication response. If you have concerns about side effects, a new prescription, or how medicines fit with your overall health, discuss them with your doctor or pharmacist.
History
In recent decades, awareness of the GFM2 gene’s role has grown. It entered the medical literature during the era when researchers were mapping genes involved in how mitochondria support the body’s energy needs. From these first observations, research expanded steadily, and the GFM2 gene was later linked to a rare inherited mitochondrial condition in affected families. This connection helped move the gene from a basic research finding into clinical genetics. Over time, descriptions became more precise as DNA sequencing made it easier to identify gene variants in children and adults with similar patterns of illness. Each stage in history has added to the picture we have today.